テデュグルチド薬の世界市場2020-2026:ガテックス、リベスティブ

QYResearchが発行した調査報告書(QYR20AP02411)
◆英語タイトル:Global Teduglutide Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026
◆商品コード:QYR20AP02411
◆発行会社(リサーチ会社):QYResearch
◆発行日:2020年3月
◆ページ数:118
◆レポート形式:英語 / PDF
◆納品方法:Eメール(受注後3営業日)
◆調査対象地域:グローバル
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD4,900 ⇒換算¥563,500見積依頼/購入/質問フォーム
Multi User(5名様閲覧用)USD7,350 ⇒換算¥845,250見積依頼/購入/質問フォーム
Enterprise License(同一法人内共有可)USD9,800 ⇒換算¥1,127,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。
※上記の日本語題名はH&Iグローバルリサーチが翻訳したものです。英語版原本には日本語表記はありません。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はQYResearch社の日本における正規代理店です。同社発行の市場リサーチレポート及びリサーチサービスに関するお問い合わせは弊社までお願い致します。QYResearch社の概要及び新刊レポートはこちらでご確認いただけます。

当リサーチレポートでは、テデュグルチド薬の世界市場規模が2019年xx百万ドルから2026年xx百万ドルまで年平均xx%成長すると予測しています。当レポートは、テデュグルチド薬のグローバル市場動向、メーカー別競争状況、種類別市場規模(ガテックス、リベスティブ)、用途別市場規模(病院、薬局、その他)、北米市場、アジア市場、中南米市場、中東・アフリカ市場分析、関連企業情報、サプライチェーン、販売チャネル分析、地域別市場規模予測データなどを掲載しています。

・レポート概要
・グローバル市場動向
・メーカー別競争状況
・テデュグルチド薬の種類別市場2015-2026:ガテックス、リベスティブ
・テデュグルチド薬の用途別市場2015-2026:病院、薬局、その他
・テデュグルチド薬の北米市場分析
・テデュグルチド薬のアジア市場分析
・テデュグルチド薬の中南米市場分析
・テデュグルチド薬の中東・アフリカ市場分析
・関連企業情報:Takeda Pharmaceuticals
・サプライチェーン及び販売チャネル分析
・地域別市場規模予測2021-2026:北米、ヨーロッパ、アジア、中南米、中東・アフリカ
・結論
【レポートの概要】

Teduglutide (brand names Gattex in the US and Revestive in Europe) is a 33-membered polypeptide and glucagon-like peptide-2 (GLP-2) analog that is used for the treatment of short bowel syndrome.In 2019, the global Teduglutide Drugs market size was US$ xx million and is forecast to US$ xx million in 2026, growing at a CAGR of xx% from 2020. In this study, 2019 has been considered as the base year and 2020 to 2026 as the forecast period to estimate the market size for Teduglutide Drugs.
The market research report offered here is a very useful resource that can help manufacturers, stakeholders, decision-makers, and other market participants to become familiar with every factor impacting the growth of the global Teduglutide Drugs market. The analysts authoring the report have closely studied key strategies adopted by top players of the global Teduglutide Drugs market. The report includes SWOT, and other market analyses to provide a clear and deep understanding of important aspects of the global Teduglutide Drugs market. Readers of the report can become informed about current and future trends of the global Teduglutide Drugs market and how they will impact market growth during the forecast period.
Geographic Segmentation
The report offers exhaustive assessment of different region-wise and country-wise Teduglutide Drugs markets such as U.S., Canada, Germany, France, U.K., Italy, Russia, China, Japan, South Korea, India, Australia, Taiwan, Indonesia, Thailand, Malaysia, Philippines, Vietnam, Mexico, Brazil, Turkey, Saudi Arabia, U.A.E etc.
For the period 2015-2026, the report provides country-wise revenue and volume sales analysis and region-wise revenue and volume analysis of the global Teduglutide Drugs market. For the period 2015-2020, it provides sales (consumption) analysis and forecast of different regional markets by Application as well as by Type in terms of volume.
Market Segmentation by Type and by Application
The report includes a detailed analysis of leading and by Type and by Application segments of the global Teduglutide Drugs market. All of the segments covered in the report are broadly analyzed based on some deciding factors. The segmental analysis section of the report offers revenue, sales analysis and forecast of the global Teduglutide Drugs market by Type and by Application segment for the period 2015-2026.

Market Segment by Type, the Teduglutide Drugs market is segmented into
Gattex
Revestive

Market Segment by Application, the Teduglutide Drugs market is segmented into
Hospital
Pharmacy
Other

This report includes the following manufacturers; we can also add the other companies as you want.
Takeda Pharmaceuticals

The study objectives are:
To analyze and research the global Teduglutide Drugs status and future forecast, involving capacity, production, value, consumption, growth rate (CAGR), market share, historical and forecast.
To present the key Teduglutide Drugs manufacturers, capacity, production, revenue, market share, and recent development for key players.
To split the breakdown data by regions, type, companies and applications.
To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
To identify significant trends, drivers, influence factors in global and regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Teduglutide Drugs are as follows:
History Year: 2015-2020
Base Year: 2019
Estimated Year: 2020
Forecast Year 2020 to 2026

【レポートの目次】

Table of Contents

1 Report Overview
1.1 Research Scope
1.2 Top Teduglutide Drugs Manufacturers Covered: Ranking by Revenue
1.3 Market Segment by Type
1.3.1 Global Teduglutide Drugs Market Size by Type: 2015 VS 2020 VS 2026 (US$ Million)
1.3.2 Gattex
1.3.3 Revestive
1.4 Market Segment by Application
1.4.1 Global Teduglutide Drugs Consumption by Application: 2015 VS 2020 VS 2026
1.4.2 Hospital
1.4.3 Pharmacy
1.4.4 Other
1.5 Study Objectives
1.6 Years Considered
2 Global Market Perspective
2.1 Global Teduglutide Drugs Revenue (2015-2026)
2.1.1 Global Teduglutide Drugs Revenue (2015-2026)
2.1.2 Global Teduglutide Drugs Sales (2015-2026)
2.2 Teduglutide Drugs Market Size across Key Geographies Worldwide: 2015 VS 2020 VS 2026
2.2.1 Global Teduglutide Drugs Sales by Regions (2015-2020)
2.2.2 Global Teduglutide Drugs Revenue by Regions (2015-2020)
2.3 Global Top Teduglutide Drugs Regions (Countries) Ranking by Market Size
2.4 Teduglutide Drugs Industry Trends
2.4.1 Teduglutide Drugs Market Top Trends
2.4.2 Market Drivers
2.4.3 Teduglutide Drugs Market Challenges
2.4.4 Porter’s Five Forces Analysis
2.4.5 Primary Interviews with Key Teduglutide Drugs Players: Views for Future

3 Competitive Landscape by Manufacturers
3.1 Global Top Teduglutide Drugs Manufacturers by Sales (2015-2020)
3.1.1 Global Teduglutide Drugs Sales by Manufacturers (2015-2020)
3.1.2 Global Teduglutide Drugs Sales Market Share by Manufacturers (2015-2020)
3.1.3 Global 5 and 10 Largest Manufacturers by Teduglutide Drugs Sales in 2019
3.2 Global Top Manufacturers Teduglutide Drugs by Revenue
3.2.1 Global Teduglutide Drugs Revenue by Manufacturers (2015-2020)
3.2.2 Global Teduglutide Drugs Revenue Share by Manufacturers (2015-2020)
3.2.3 Global Teduglutide Drugs Market Concentration Ratio (CR5 and HHI)
3.3 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teduglutide Drugs as of 2019)
3.4 Global Teduglutide Drugs Average Selling Price (ASP) by Manufacturers
3.5 Key Manufacturers Teduglutide Drugs Plants/Factories Distribution and Area Served
3.6 Date of Key Manufacturers Enter into Teduglutide Drugs Market
3.7 Key Manufacturers Teduglutide Drugs Product Offered
3.8 Mergers & Acquisitions, Expansion Plans

4 Market Size by Type
4.1 Global Teduglutide Drugs Historic Market Review by Type (2015-2020)
4.1.2 Global Teduglutide Drugs Sales Market Share by Type (2015-2020)
4.1.3 Global Teduglutide Drugs Revenue Market Share by Type (2015-2020)
4.1.4 Teduglutide Drugs Price by Type (2015-2020)
4.1 Global Teduglutide Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.2 Global Teduglutide Drugs Sales Forecast by Type (2021-2026)
4.2.3 Global Teduglutide Drugs Revenue Forecast by Type (2021-2026)
4.2.4 Teduglutide Drugs Price Forecast by Type (2021-2026)

5 Global Teduglutide Drugs Market Size by Application
5.1 Global Teduglutide Drugs Historic Market Review by Application (2015-2020)
5.1.2 Global Teduglutide Drugs Sales Market Share by Application (2015-2020)
5.1.3 Global Teduglutide Drugs Revenue Market Share by Application (2015-2020)
5.1.4 Teduglutide Drugs Price by Application (2015-2020)
5.2 Global Teduglutide Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.2 Global Teduglutide Drugs Sales Forecast by Application (2021-2026)
5.2.3 Global Teduglutide Drugs Revenue Forecast by Application (2021-2026)
5.2.4 Teduglutide Drugs Price Forecast by Application (2021-2026)

6 North America
6.1 North America Teduglutide Drugs Breakdown Data by Company
6.2 North America Teduglutide Drugs Breakdown Data by Type
6.3 North America Teduglutide Drugs Breakdown Data by Application
6.4 North America Teduglutide Drugs Breakdown Data by Countries
6.4.1 North America Teduglutide Drugs Sales by Countries
6.4.2 North America Teduglutide Drugs Revenue by Countries
6.4.3 U.S.
6.4.4 Canada

7 Europe
7.1 Europe Teduglutide Drugs Breakdown Data by Company
7.2 Europe Teduglutide Drugs Breakdown Data by Type
7.3 Europe Teduglutide Drugs Breakdown Data by Application
7.4 Europe Teduglutide Drugs Breakdown Data by Countries
7.4.1 Europe Teduglutide Drugs Sales by Countries
7.4.2 Europe Teduglutide Drugs Revenue by Countries
7.4.3 Germany
7.4.4 France
7.4.5 U.K.
7.4.6 Italy
7.4.7 Russia

8 Asia Pacific
8.1 Asia Pacific Teduglutide Drugs Breakdown Data by Company
8.2 Asia Pacific Teduglutide Drugs Breakdown Data by Type
8.3 Asia Pacific Teduglutide Drugs Breakdown Data by Application
8.4 Asia Pacific Teduglutide Drugs Breakdown Data by Regions
8.4.1 Asia Pacific Teduglutide Drugs Sales by Regions
8.4.2 Asia Pacific Teduglutide Drugs Revenue by Regions
8.4.3 China
8.4.4 Japan
8.4.5 South Korea
8.4.6 India
8.4.7 Australia
8.4.8 Taiwan
8.4.9 Indonesia
8.4.10 Thailand
8.4.11 Malaysia
8.4.12 Philippines
8.4.13 Vietnam

9 Latin America
9.1 Latin America Teduglutide Drugs Breakdown Data by Company
9.2 Latin America Teduglutide Drugs Breakdown Data by Type
9.3 Latin America Teduglutide Drugs Breakdown Data by Application
9.4 Latin America Teduglutide Drugs Breakdown Data by Countries
9.4.1 Latin America Teduglutide Drugs Sales by Countries
9.4.2 Latin America Teduglutide Drugs Revenue by Countries
9.4.3 Mexico
9.4.4 Brazil
9.4.5 Argentina

10 Middle East and Africa
10.1 Middle East and Africa Teduglutide Drugs Breakdown Data by Type
10.2 Middle East and Africa Teduglutide Drugs Breakdown Data by Application
10.3 Middle East and Africa Teduglutide Drugs Breakdown Data by Countries
10.3.1 Middle East and Africa Teduglutide Drugs Sales by Countries
10.3.2 Middle East and Africa Teduglutide Drugs Revenue by Countries
10.3.3 Turkey
10.3.4 Saudi Arabia
10.3.5 U.A.E

11 Company Profiles
11.1 Takeda Pharmaceuticals
11.1.1 Takeda Pharmaceuticals Corporation Information
11.1.2 Takeda Pharmaceuticals Business Overview and Total Revenue (2019 VS 2018)
11.1.3 Takeda Pharmaceuticals Teduglutide Drugs Sales, Revenue, Average Selling Price (ASP) and Gross Margin (2015-2020)
11.1.4 Takeda Pharmaceuticals Teduglutide Drugs Products and Services
11.1.5 Takeda Pharmaceuticals SWOT Analysis
11.1.6 Takeda Pharmaceuticals Recent Developments

12 Supply Chain and Sales Channels Analysis
12.1 Supply Chain Analysis
12.2 Sales Channels Analysis
12.2.1 Teduglutide Drugs Sales Channels
12.2.2 Teduglutide Drugs Distributors
12.3 Teduglutide Drugs Customers

13 Estimates and Projections by Regions (2021-2026)
13.1 Global Teduglutide Drugs Sales Forecast (2021-2026)
13.1.1 Global Teduglutide Drugs Sales Forecast by Regions (2021-2026)
13.1.2 Global Teduglutide Drugs Revenue Forecast by Regions (2021-2026)
13.2 North America Market Size Forecast (2021-2026)
13.2.1 North America Teduglutide Drugs Sales Forecast (2021-2026)
13.2.2 North America Teduglutide Drugs Revenue Forecast (2021-2026)
13.2.3 North America Teduglutide Drugs Size Forecast by County (2021-2026)
13.3 Europe Market Size Forecast (2021-2026)
13.3.1 Europe Teduglutide Drugs Sales Forecast (2021-2026)
13.3.2 Europe Teduglutide Drugs Revenue Forecast (2021-2026)
13.3.3 Europe Teduglutide Drugs Size Forecast by County (2021-2026)
13.4 Asia Pacific Market Size Forecast (2021-2026)
13.4.1 Asia Pacific Teduglutide Drugs Sales Forecast (2021-2026)
13.4.2 Asia Pacific Teduglutide Drugs Revenue Forecast (2021-2026)
13.4.3 Asia Pacific Teduglutide Drugs Size Forecast by Region (2021-2026)
13.5 Latin America Market Size Forecast (2021-2026)
13.5.1 Latin America Teduglutide Drugs Sales Forecast (2021-2026)
13.5.2 Latin America Teduglutide Drugs Revenue Forecast (2021-2026)
13.5.3 Latin America Teduglutide Drugs Size Forecast by County (2021-2026)
13.6 Middle East and Africa Market Forecast
13.6.1 Middle East and Africa Teduglutide Drugs Sales Forecast (2021-2026)
13.6.2 Middle East and Africa Teduglutide Drugs Revenue Forecast (2021-2026)
13.6.3 Middle East and Africa Teduglutide Drugs Size Forecast by County (2021-2026)

14 Research Findings and Conclusion

15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Author Details
15.3 Disclaimer

List of Tables
Table 1. Teduglutide Drugs Key Market Segments
Table 2. Ranking of Global Top Teduglutide Drugs Manufacturers by Revenue (US$ Million) in 2019
Table 3. Global Teduglutide Drugs Market Size Growth Rate by Type 2021-2026 (K Units) & (Million US$)
Table 4. Major Manufacturers of Gattex
Table 5. Major Manufacturers of Revestive
Table 6. Global Teduglutide Drugs Market Share by Application 2019-2025 (K Units)
Table 7. Global Teduglutide Drugs Market Size by Regions 2015-2020 (K Units) & (Million US$)
Table 8. Global Teduglutide Drugs Sales by Regions 2015-2020 (K Units)
Table 9. Global Teduglutide Drugs Sales Market Share by Regions 2015-2020
Table 10. Global Teduglutide Drugs Revenue by Regions 2015-2020 (Million US$)
Table 11. Global Teduglutide Drugs Revenue Market Share by Regions 2015-2020
Table 12. Top Teduglutide Drugs Regions (Countries) Ranking by Market Size (US$ Million) in 2019
Table 13. Market Top Trends
Table 14. Teduglutide Drugs Key Drivers: Impact Analysis (2021-2026)
Table 15. Teduglutide Drugs Key Challenges
Table 16. Main Points Interviewed from Key Teduglutide Drugs Players: Views for Future
Table 17. Global Teduglutide Drugs Sales by Manufacturers (2015-2020) (K Units)
Table 18. Global Teduglutide Drugs Sales Share by Manufacturers (2015-2020)
Table 19. Teduglutide Drugs Revenue by Manufacturers (2015-2020) (Million US$)
Table 20. Teduglutide Drugs Revenue Share by Manufacturers (2015-2020)
Table 21. Global Teduglutide Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 22. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Teduglutide Drugs as of 2019)
Table 23. Key Manufacturers Teduglutide Drugs Average Selling Price (ASP) (2015-2020) (USD/Unit)
Table 24. Key Manufacturers Teduglutide Drugs Plants/Factories Distribution
Table 25. Key Manufacturers Teduglutide Drugs Area Served
Table 26. Date of Key Manufacturers Enter into Teduglutide Drugs Market
Table 27. Key Manufacturers Teduglutide Drugs Product Type
Table 28. Mergers & Acquisitions, Expansion Plans
Table 29. Global Gattex Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 30. Global Revestive Sales and Revenue (2015-2020) (K Units) & (Million US$)
Table 31. Global Teduglutide Drugs Sales (K Units) by Type (2015-2020)
Table 32. Global Teduglutide Drugs Sales Share by Type (2015-2020)
Table 33. Global Teduglutide Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 34. Global Teduglutide Drugs Price (K Units) by Type (2015-2020)
Table 35. Global Teduglutide Drugs Sales (K Units) by Type (2021-2026)
Table 36. Global Teduglutide Drugs Sales Share by Type (2021-2026)
Table 37. Global Teduglutide Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 38. Global Teduglutide Drugs Revenue Share by Type (2021-2026)
Table 39. Global Teduglutide Drugs Price (K Units) by Type (2021-2026)
Table 40. Global Teduglutide Drugs Sales (K Units) by Application (2015-2020)
Table 41. Global Teduglutide Drugs Sales Share by Application (2015-2020)
Table 42. Global Teduglutide Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 43. Global Teduglutide Drugs Price by Application 2015-2020 (USD/Unit)
Table 44. Global Teduglutide Drugs Sales by Application (2015-2020) (K Units)
Table 45. Global Teduglutide Drugs Sales Share by Application (2015-2020)
Table 46. Global Teduglutide Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 47. Global Teduglutide Drugs Revenue Share by Application (2021-2026)
Table 48. Global Teduglutide Drugs Price (K Units) by Application (2021-2026)
Table 49. North America Teduglutide Drugs Sales by Company (2015-2020) (K Units)
Table 50. North America Teduglutide Drugs Sales Market Share by Company (2015-2020)
Table 51. North America Teduglutide Drugs Sales by Type (2015-2020) (K Units)
Table 52. North America Teduglutide Drugs Sales Market Share by Type (2015-2020)
Table 53. North America Teduglutide Drugs Sales by Application (2015-2020) (K Units)
Table 54. North America Teduglutide Drugs Sales Market Share by Application (2015-2020)
Table 55. North America Teduglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 56. North America Teduglutide Drugs Sales Market Share by Countries (2015-2020)
Table 57. North America Teduglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 58. North America Teduglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 59. Europe Teduglutide Drugs Sales by Company (2015-2020) (K Units)
Table 60. Europe Teduglutide Drugs Sales Market Share by Company (2015-2020)
Table 61. Europe Teduglutide Drugs Sales by Type (2015-2020) (K Units)
Table 62. Europe Teduglutide Drugs Sales Market Share by Type (2015-2020)
Table 63. Europe Teduglutide Drugs Sales by Application (2015-2020) (K Units)
Table 64. Europe Teduglutide Drugs Sales Market Share by Application (2015-2020)
Table 65. Europe Teduglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 66. Europe Teduglutide Drugs Sales Market Share by Countries (2015-2020)
Table 67. Europe Teduglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 68. Europe Teduglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 69. Asia Pacific Teduglutide Drugs Sales by Regions (2015-2020) (K Units)
Table 70. Asia Pacific Teduglutide Drugs Sales Market Share by Regions (2015-2020)
Table 71. Asia Pacific Teduglutide Drugs Sales by Type (2015-2020) (K Units)
Table 72. Asia Pacific Teduglutide Drugs Sales Market Share by Type (2015-2020)
Table 73. Asia Pacific Teduglutide Drugs Sales by Application (2015-2020) (K Units)
Table 74. Asia Pacific Teduglutide Drugs Sales Market Share by Application (2015-2020)
Table 75. Asia Pacific Teduglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 76. Asia Pacific Teduglutide Drugs Sales Market Share by Regions (2015-2020)
Table 77. Asia Pacific Teduglutide Drugs Revenue by Regions (2015-2020) (Million US$)
Table 78. Asia Pacific Teduglutide Drugs Revenue Market Share by Regions (2015-2020)
Table 79. Latin America Teduglutide Drugs Sales by Company (2015-2020) (K Units)
Table 80. Latin America Teduglutide Drugs Sales Market Share by Company (2015-2020)
Table 81. Latin America Teduglutide Drugs Sales by Type (2015-2020) (K Units)
Table 82. Latin America Teduglutide Drugs Sales Market Share by Type (2015-2020)
Table 83. Latin America Teduglutide Drugs Sales by Application (2015-2020) (K Units)
Table 84. Latin America Teduglutide Drugs Sales Market Share by Application (2015-2020)
Table 85. Latin America Teduglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 86. Latin America Teduglutide Drugs Sales Market Share by Countries (2015-2020)
Table 87. Latin America Teduglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 88. Latin America Teduglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 89. Middle East and Africa Teduglutide Drugs Sales by Type (2015-2020) (K Units)
Table 90. Middle East and Africa Teduglutide Drugs Sales Market Share by Type (2015-2020)
Table 91. Middle East and Africa Teduglutide Drugs Sales by Application (2015-2020) (K Units)
Table 92. Middle East and Africa Teduglutide Drugs Sales Market Share by Application (2015-2020)
Table 93. Middle East and Africa Teduglutide Drugs Sales by Countries (2015-2020) (K Units)
Table 94. Middle East and Africa Teduglutide Drugs Sales Market Share by Countries (2015-2020)
Table 95. Middle East and Africa Teduglutide Drugs Revenue by Countries (2015-2020) (Million US$)
Table 96. Middle East and Africa Teduglutide Drugs Revenue Market Share by Countries (2015-2020)
Table 97. Takeda Pharmaceuticals Company Details
Table 98. Takeda Pharmaceuticals Description and Business Overview
Table 99. Takeda Pharmaceuticals Teduglutide Drugs Sales (K Units), Revenue (Million US$), Price (USD/Unit) and Gross Margin (2015-2020)
Table 100. Takeda Pharmaceuticals Teduglutide Drugs Sales Growth Rate (2015-2020)
Table 101. Takeda Pharmaceuticals Teduglutide Drugs Sales Market Share in Global Market
Table 102. Takeda Pharmaceuticals Recent Development
Table 103. Teduglutide Drugs Distributors List
Table 104. Teduglutide Drugs Customers List
Table 105. Global Teduglutide Drugs Sales Forecast 2021-2026 (K Units) & (Million US$)
Table 106. Global Teduglutide Drugs Sales Forecast by Type 2021-2026 (K Units)
Table 107. Global Teduglutide Drugs Sales Forecast by Application 2021-2026 (K Units)
Table 108. Global Teduglutide Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 109. Global Teduglutide Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 110. North America Teduglutide Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 111. North America Teduglutide Drugs Revenue Forecast by Countries 2021-2026
Table 112. Europe Teduglutide Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 113. Europe Teduglutide Drugs Revenue Market Share Forecast by Countries 2021-2026
Table 114. Asia Pacific Teduglutide Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 115. Asia Pacific Teduglutide Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 116. Latin America Teduglutide Drugs Sales Forecast by Countries 2021-2026 (K Units)
Table 117. Latin America Teduglutide Drugs Revenue Forecast by Countries 2021-2026 (Million US$)
Table 118. Middle East and Africa Teduglutide Drugs Sales Forecast by Regions 2021-2026 (K Units)
Table 119. Middle East and Africa Teduglutide Drugs Revenue Forecast by Regions 2021-2026 (Million US$)
Table 120. Research Programs/Design for This Report
Table 121. Key Data Information from Secondary Sources
Table 122. Key Data Information from Primary Sources
List of Figures
Figure 1. Teduglutide Drugs Product Picture
Figure 2. Global Teduglutide Drugs Sales Market Shar by Type 2015-2026
Figure 3. Gattex Figures
Figure 4. Revestive Figures
Figure 5. Global Teduglutide Drugs Sales Market Share by Application in 2019 & 2026
Figure 6. Hospital Use Case
Figure 7. Pharmacy Use Case
Figure 8. Other Use Case
Figure 9. Teduglutide Drugs Report Years Considered
Figure 10. Global Teduglutide Drugs Market Size 2015-2026 (Million US$)
Figure 11. Global Teduglutide Drugs Sales 2015-2020 (K Units)
Figure 12. Global Teduglutide Drugs Market Size Market Share by Regions 2015-2020
Figure 13. Global Teduglutide Drugs Sales Market Share by Regions in 2019
Figure 14. Porter's Five Forces Analysis
Figure 15. Global Teduglutide Drugs Sales Share by Manufacturers in 2019
Figure 16. The 5 and 10 Largest Manufacturers in the World: Market Share by Teduglutide Drugs Sales in 2019
Figure 17. Teduglutide Drugs Value Share by Manufacturers in 2019
Figure 18. Teduglutide Drugs Revenue Share by Manufacturers In 2019
Figure 19. Teduglutide Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 20. Global Teduglutide Drugs Revenue Share by Type (2015-2020)
Figure 21. Global Teduglutide Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 22. Global Teduglutide Drugs Market Share by Price Range (2015-2020)
Figure 23. Global Teduglutide Drugs Revenue Share by Application (2015-2020)
Figure 24. Global Teduglutide Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 25. North America Teduglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 26. U.S. Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 27. Canada Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 28. Europe Teduglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 29. Germany Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 30. France Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 31. U.K. Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 32. Italy Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 33. Russia Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 34. Asia Pacific Teduglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 35. China Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 36. Japan Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 37. South Korea Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 38. India Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 39. Australia Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 40. Taiwan Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 41. Indonesia Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 42. Thailand Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 43. Malaysia Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 44. Philippines Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 45. Vietnam Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 46. Latin America Teduglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 47. Mexico Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 48. Brazil Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 49. Argentina Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 50. Middle East and Africa Teduglutide Drugs Revenue Growth Rate 2015-2020 (Million US$)
Figure 51. Turkey Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 52. Saudi Arabia Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 53. U.A.E Teduglutide Drugs Sales Growth Rate (2015-2020) (K Units)
Figure 54. Takeda Pharmaceuticals Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. Teduglutide Drugs Value Chain
Figure 56. Channels of Distribution
Figure 57. Distributors Profiles
Figure 58. North America Teduglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 59. North America Teduglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 60. Europe Teduglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 61. Europe Teduglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 62. Asia Pacific Teduglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 63. Asia Pacific Teduglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 64. Latin America Teduglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 65. Latin America Teduglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 66. Middle East and Africa Teduglutide Drugs Sales Growth Rate Forecast (2021-2026) (K Units)
Figure 67. Middle East and Africa Teduglutide Drugs Revenue Growth Rate Forecast (2021-2026) (US$ Million)
Figure 68. Bottom-up and Top-down Approaches for This Report
Figure 69. Data Triangulation
Figure 70. Key Executives Interviewed


【掲載企業】

Takeda Pharmaceuticals

【免責事項】
https://www.globalresearch.jp/disclaimer

★リサーチレポート[ テデュグルチド薬の世界市場2020-2026:ガテックス、リベスティブ(Global Teduglutide Drugs Industry Research Report, Growth Trends and Competitive Analysis 2020-2026)]についてメールでお問い合わせはこちらでお願いします。